Home
Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 25/08/28
Trade details
- Type
- Insider sale
- Amount
- $8,135.7
- Shares · price
- 470 sh · $17.31 a share
- Held after
- 92,656 sh
- Person
- Christopher R. ClineCFO
- Trade date
- 25/08/27
- Filed
- 25/08/28
- Days to filing
- 1 days
Sold 0.5% of holdings
- Share of holding sold
- 0.5%
Travere Therapeutics trades, last 26 weeks
What else happened in Travere Therapeutics around then
Filed or reported within 30 days of the trade day · 25/07/28~25/09/26Christopher R. Cline's recent trades
- Christopher R. Cline
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 planTravere Therapeutics
TVTX
$3.3M
50,508 sh
$3.3M
Filed 09/15
Traded 09/15
- Christopher R. Cline
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 planTravere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/06
Traded 05/05
- Christopher R. Cline
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 planTravere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
- Christopher R. Cline
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 planTravere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
- Christopher R. Cline
Planned saleTravere Therapeutics
Planned saleTravere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/05
Traded 05/05